- Bocicor MI, Molnar A-J, Taslitchi C. Preventing hospital acquired infections through a workflow-based
cyber-physical system. arXiv preprint arXiv:170208010. 2017.
2. Dasgupta S, Das S, Chawan NS, Hazra A. Nosocomial infections in the intensive care unit: Incidence,
risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India. J Crit Care
Med. 2015;19(1):14.
3. Khan HA, Baig FK, Mehboob R. Nosocomial infections: Epidemiology, prevention, control and
surveillance. Asian Pacific Journal of Tropical Biomedicine. 2017;7(5):478-82.
4. Krause G. Changing Infection Patterns: New Evidence on the Prevalence of Nosocomial Infections and
Antibiotic Resistance in Hospitals in Germany. Deutsches Ärzteblatt International. 2017;114(50):849.
5. Stiller A, Schröder C, Gropmann A, Schwab F, Behnke M, Geffers C, et al. ICU ward design and
nosocomial infection rates: a cross-sectional study in Germany. Journal of Hospital Infection. 2017;95(1):71-5.
- 6. Edwardson S, Cairns C. Nosocomial infections in the ICU. Anaesthesia & Intensive Care Medicine.
2018;20(1):14-8.
7. Ierano C, Nankervis J-AM, James R, Rajkhowa A, Peel T, Thursky K. Surgical antimicrobial
prophylaxis. Australian prescriber. 2017;40(6):225.
8. Strymish J, Branch-Elliman W, Itani K, Gupta K, editors. National Trends in Vancomycin use for PeriOperative Prophylaxis Over 5 Years. Open Forum Infectious Diseases; 2015: Infectious Diseases Society of
America.
9. Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease
Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA surgery.
2017;152(8):784-91.
10. Tita AT, Rouse DJ, Blackwell S, Saade GR, Spong CY, Andrews WW. Evolving concepts in antibiotic
prophylaxis for cesarean delivery: A systematic review. Obstetrics and gynecology. 2009;113(3):675.
11. Tita AT, Szychowski JM, Boggess K, Saade G, Longo S, Clark E, et al. Adjunctive azithromycin
prophylaxis for cesarean delivery. New England journal of medicine. 2016;375(13):1231-41.
12. Das S, Adler AL, Miles-Jay A, Kronman MP, Qin X, Weissman SJ, et al. Antibiotic prophylaxis is
associated with subsequent resistant infections in children with an initial extended-spectrum-cephalosporinresistant Enterobacteriaceae infection. Antimicrobial agents and chemotherapy. 2017;61(5):e02656-16.
13. Adrie C, Garrouste-Orgeas M, Essaied WI, Schwebel C, Darmon M, Mourvillier B, et al. Attributable
mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance
profile and antimicrobial therapy. J Infect. 2017;74(2):131-41.
14. Lee HJ, Jeong JS, Ki HK, Lee SI. Comparison between the Surveillance Definitions for Nosocomial
Pneumonia Published by the CDC in 1996 and 2002. Korean Journal of Nosocomial Infection Control.
2009;14(1):51-9.
15. Olgac G, Aydogmus U, Mulazimoglu L, Kutlu CA. Antibiotics are not needed during tube thoracostomy
for spontaneous pneumothorax: an observational case study. J Cardiothorac Surg. 2006;1(1):43.
16. Ravikumar V, Ho AL, Pendharkar AV, Sussman ES, Kwong-hon Chow K, Li G. The use of vancomycin
powder for surgical prophylaxis following craniotomy. Neurosurgery. 2017;80(5):754-8.
17. Scheverin N, Steverlynck A, Castelli R, Sobrero D, Kopp NV, Dinelli D, et al. Prophylaxis of surgical
site infection with vancomycin in 513 patients that underwent to lumbar fusion. Coluna/Columna.
2015;14(3):177-80.
18. Cohen-Rosenblum A, Crutcher M, Gui J, Novicoff W, Nelson S, Browne J. Dual Antibiotic Therapy
with Vancomycin and Cefazolin for Surgical Prophylaxis in Total Knee Arthroplasty. Reconstructive Review.
2018;8(2).
19. Hagel S, Scheuerlein H. Perioperative antibiotic prophylaxis and antimicrobial therapy of intraabdominal infections. Visceral Medicine. 2014;30(5):310-6.
20. Sepehr A, Santos BJG, Chou C, Karimi K, Devcic Z, Oels S, et al. Antibiotics in head and neck surgery
in the setting of malnutrition, tracheotomy, and diabetes. The Laryngoscope. 2009;119(3):549-53.
21. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after
cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation.
2000;101(25):2916-21.
22. Torres A, Ewig S, Lode H, Carlet J, Group EHW. Defining, treating and preventing hospital acquired
pneumonia: European perspective. Intensive care medicine. 2009;35(1):9-29.
23. Alverdy JC, Laughlin RS, Wu L. Influence of the critically ill state on host-pathogen interactions within
the intestine: gut-derived sepsis redefined. Critical care medicine. 2003;31(2):598-607.
24. Forestier C, Guelon D, Cluytens V, Gillart T, Sirot J, De Champs C. Oral probiotic and prevention of
Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care
unit patients. Critical Care. 2008;12(3):R69.
25. Oudhuis GJ, Stobberingh EE, Kessels A, Bergmans DC, Dormans T, Verbon A. Infection prevention in
Intensive Care patients using the probiotic Lactobacillus plantarum 299/299v. Infection prevention in Intensive
Care patients: probiotics compared to antibiotics. 2012:87.
26. Liu K-x, Qu J-m, Zhang J, Lin Q-c. Probiotic Prophylaxis of Nosocomial Pneumonia in Critically Ill
Patients. Diet and Nutrition in Critical Care. 2014:1-17.
27. Rotstein C, Evans G, Born A, Grossman R, Light RB, Magder S, et al. Clinical practice guidelines for
hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Canadian Journal of Infectious
Diseases and Medical Microbiology. 2008;19(1):19-53.
28. Haas JP, Evans AM, Preston KE, Larson EL. Risk factors for surgical site infection after cardiac surgery:
the role of endogenous flora. Heart & Lung. 2005;34(2):108-14.
- 29. Branch-Elliman W, Ripollone JE, O’Brien WJ, Itani KM, Schweizer ML, Perencevich E, et al. Risk of
surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis
with vancomycin plus a beta-lactam versus either drug alone: a national propensity-score-adjusted retrospective
cohort study. PLoS medicine. 2017;14(7):e1002340.
30. Mireya UA, Marti PO, Xavier KV, Cristina LO, Miguel MM, Magda CM. Nosocomial infections in
paediatric and neonatal intensive care units. J Infect. 2007;54(3):212-20.
31. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during
hospitalization. Jama. 2003;290(14):1868-74.
32. Feldman C. An overview of nosocomial pneumonia. Southern African Journal of Epidemiology and
Infection. 2005;20(2):49-57.
33. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units
in Argentina: attributable mortality and length of stay. Am J Infect Control. 2003;31(5):291-5.
34. Wang J, Gao P, Guo S, Liu Y, Shao L, Kang H, et al. Analysis of death risk factors for nosocomial
infection patients in an ICU: a retrospective review of 864 patients from 2009 to 2015. Zhongguo Wei Zhong
Bing Ji Jiu Yi Xue. 2016;28(8):704-8.
35. Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Rüden H. Mortality risk factors with nosocomial
Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection
Surveillance System (KISS). Infection. 2005;33(2):50-5.
36. Cevik M, Yilmaz G, Erdinc F, Ucler S, Tulek N. Relationship between nosocomial infection and
mortality in a neurology intensive care unit in Turkey. Journal of Hospital Infection. 2005;59(4):324-30.
37. Custovic A, Smajlovic J, Hadzic S, Ahmetagic S, Tihic N, Hadzagic H. Epidemiological surveillance of
bacterial nosocomial infections in the surgical intensive care unit. Materia socio-medica. 2014;26(1):7-11.
38. Geffers C, Gastmeier P. Nosocomial infections and multidrug-resistant organisms in Germany:
epidemiological data from KISS (the Hospital Infection Surveillance System). Deutsches Ärzteblatt International.
2011;108(6):87-93.
39. Jahani-Sherafat S, Razaghi M, Rosenthal VD, Tajeddin E, Seyedjavadi S, Rashidan M, et al. Deviceassociated infection rates and bacterial resistance in six academic teaching hospitals of Iran: Findings from the
International Nocosomial Infection Control Consortium (INICC). J Infect Public Health. 2015;8(6):553-61.
40. Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections
due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis. 2003;36(10):1268-74.
|
